HealthAgentBench: New benchmark for AI agents in healthcare

HealthAgentBench: 54 realistic tasks to evaluate AI agents in healthcare. Only the best model achieves a 42% success rate. Discover its strengths and weaknesses.

miércoles, 1 de julio de 2026 • 3 min read • Q2BSTUDIO Team

Evaluating frontier agents in clinical tasks

The rise of artificial intelligence agents in the healthcare sector promises to transform everything from diagnosis to patient management. However, for these tools to be truly useful in clinical settings, they must undergo rigorous evaluations that reflect the complexity of the real world. HealthAgentBench emerges as a benchmark specifically designed to measure the capabilities of AI agents in long-range healthcare tasks, covering 54 activities distributed across seven categories that span various stages of the patient journey and data modalities.

Unlike simplified tests, this benchmark replicates complete clinical workflows: the agent receives minimal instructions and must explore raw healthcare data, operate in complex environments, and execute multi-step solutions that go beyond simple queries. The result is measured through a final success rate, offering a clear metric of overall performance. When evaluating the most advanced agents, it is observed that even the best, Codex GPT-5.5, barely achieves a 42% success rate, highlighting the difficulty of the task set and the wide margin for improvement that exists.

HealthAgentBench reveals specific strengths and weaknesses. Agents show some proficiency in the automated development of modeling pipelines on electronic health record (EHR) data, but they stumble significantly in medical image analysis, an area where Claude Code models present difficulties while Codex GPT-5.5 is beginning to stand out. Tasks that combine large search spaces with compositional reasoning remain a major challenge for all current systems. This underscores the need to integrate more sophisticated multimodal and reasoning capabilities into AI agents for companies seeking reliable healthcare applications.

For the technology industry, this benchmark represents a wake-up call. Developing agents capable of handling real clinical workflows requires not only advanced algorithms, but also robust infrastructures that support the processing of large volumes of multimodal data. This is where AWS and Azure cloud services come into play, providing the necessary scalability, as well as cybersecurity to protect sensitive patient information. Furthermore, the integration of business intelligence tools such as Power BI allows for monitoring and visualizing the performance of these agents, facilitating informed decision-making.

In this context, companies like Q2BSTUDIO offer key solutions to address these challenges. Our experience in custom application development and custom software allows us to build systems tailored to the specific needs of each healthcare organization. Likewise, we have specialized services in artificial intelligence for companies, helping to implement AI agents that can overcome benchmarks like HealthAgentBench. We combine this with a solid offering in AWS and Azure cloud services, cybersecurity, and business intelligence services, ensuring that each solution is secure, scalable, and results-oriented. If you would like to delve deeper into how artificial intelligence can transform your organization, visit our page on AI for companies.

In short, HealthAgentBench marks a milestone in the evaluation of healthcare agents, but the path toward widespread clinical adoption is still long. Collaboration between realistic benchmarks, robust cloud technologies, and development companies with strategic vision will be essential to achieve AI agents that truly assist healthcare professionals and improve patient care. Q2BSTUDIO is ready to be part of that advancement.

A BREAK?

Play for a moment before you go

OUR SERVICES

How we can help you

Do you have a project in mind?

Tell us your vision and we'll turn it into a software solution. Whatever the scope, we make your idea real.